NASDAQ
Cabaletta Bio, Inc. (CABA) has a free cash flow growth of -19.73% as of Friday, May 29, 2026. This represents a 67.49% decrease compared to its 12-month average of -11.78%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.